{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:45:12Z","timestamp":1792727112153,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and the Engineering Research Council of Canada.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.antiviral.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T17:16:20Z","timestamp":1409591780000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein"],"prefix":"10.1016","volume":"111","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Picard-Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Lariv\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bisaillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.08.012_b0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jmv.20171","article-title":"Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface","volume":"74","author":"Andersen","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0010","doi-asserted-by":"crossref","first-page":"9833","DOI":"10.1074\/jbc.R500026200","article-title":"From structure to function: new insights into hepatitis C virus RNA replication","volume":"281","author":"Appel","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.08.012_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.antiviral.2004.05.002","article-title":"Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo","volume":"63","author":"Beljaars","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0020","first-page":"417","article-title":"Impairment of circulating lactoferrin in HIV-1 infection","volume":"41","author":"Defer","year":"1995","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"key":"10.1016\/j.antiviral.2014.08.012_b0025","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/IAI.56.11.2774-2781.1988","article-title":"Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin","volume":"56","author":"Ellison","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2014.08.012_b0030","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/BF01322673","article-title":"Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea","volume":"140","author":"Fujihara","year":"1995","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.170.2.415","article-title":"Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity","volume":"170","author":"Furmanski","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2014.08.012_b0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"issue":"301","key":"10.1016\/j.antiviral.2014.08.012_b0045","first-page":"e301","article-title":"Lactoferrin: structure, function and applications","volume":"33","author":"Gonzalez-Chavez","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2014.08.012_b0050","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/474S2a","article-title":"Introduction: a smouldering public-health crisis","volume":"474","author":"Gravitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.08.012_b0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/infdis\/172.2.380","article-title":"Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro","volume":"172","author":"Harmsen","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.08.012_b0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hepres.2004.01.002","article-title":"A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load","volume":"29","author":"Hirashima","year":"2004","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-1702(99)00121-5","article-title":"Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells","volume":"66","author":"Ikeda","year":"2000","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.hepres.2005.03.018","article-title":"Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C","volume":"32","author":"Ishibashi","year":"2005","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0075","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1572-0241.2002.05573.x","article-title":"Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b","volume":"97","author":"Iwasa","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0080","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1086\/520886","article-title":"Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes","volume":"196","author":"Janssen","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.08.012_b0085","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/jcp.22650","article-title":"Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells","volume":"226","author":"Jiang","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0090","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1440-1746.2007.04858.x","article-title":"Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin","volume":"22","author":"Kaito","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.exer.2007.09.013","article-title":"Lactoferrin Glu561Asp polymorphism is associated with susceptibility to herpes simplex keratitis","volume":"86","author":"Keijser","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/infdis\/124.6.539","article-title":"Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis","volume":"124","author":"Kirkpatrick","year":"1971","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.08.012_b0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijantimicag.2010.08.020","article-title":"Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial alpha beta region","volume":"37","author":"Kondori","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2014.08.012_b0110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/JVI.80.1.404-411.2006","article-title":"Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase","volume":"80","author":"Lam","year":"2006","journal-title":"J. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2014.08.012_b0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2014.08.012_b0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1432-1033.2003.03929.x","article-title":"Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells","volume":"271","author":"Legrand","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.antiviral.2014.08.012_b0125","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.antiviral.2014.08.012_b0130","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1128\/JVI.71.11.8416-8428.1997","article-title":"Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity","volume":"71","author":"Lohmann","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0135","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/512199","article-title":"A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico","volume":"44","author":"Mohamed","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.08.012_b0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.08.012_b0145","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1349-7006.2002.tb02484.x","article-title":"Dose\u2013response trial of lactoferrin in patients with chronic hepatitis C","volume":"93","author":"Okada","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0304-4165(68)90015-9","article-title":"Inhibition of bacteria by lactoferrin and other iron-chelating agents","volume":"170","author":"Oram","year":"1968","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2014.08.012_b0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrmicro1972","article-title":"Avoiding the void: cell-to-cell spread of human viruses","volume":"6","author":"Sattentau","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004300050049","article-title":"Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29","volume":"186","author":"Superti","year":"1997","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1349-7006.1999.tb00756.x","article-title":"Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study","volume":"90","author":"Tanaka","year":"1999","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0175","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.08.012_b0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell\u2013cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.08.012_b0185","first-page":"1077","article-title":"Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease","volume":"17","author":"Tuccari","year":"2002","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.antiviral.2014.08.012_b0190","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1349-7006.2006.00274.x","article-title":"Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C","volume":"97","author":"Ueno","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.antiviral.2014.08.012_b0195","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1128\/IAI.71.11.6141-6147.2003","article-title":"One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis","volume":"71","author":"Velliyagounder","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2014.08.012_b0200","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1128\/AAC.48.4.1242-1248.2004","article-title":"Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity","volume":"48","author":"Viejo-Diaz","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.08.012_b0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1600-0765.2008.01120.x","article-title":"Association between lactoferrin gene polymorphisms and aggressive periodontitis among Taiwanese patients","volume":"44","author":"Wu","year":"2009","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.antiviral.2014.08.012_b0210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/IAI.61.2.719-728.1993","article-title":"Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment","volume":"61","author":"Yamauchi","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2014.08.012_b0215","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/JVI.71.8.5997-6002.1997","article-title":"Hepatitis C virus envelope proteins bind lactoferrin","volume":"71","author":"Yi","year":"1997","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T23:36:49Z","timestamp":1598225809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":43,"alternative-id":["S0166354214002496"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.08.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}